BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30442225)

  • 1. Relation of Vasoplegia in the Absence of Primary Graft Dysfunction to Mortality Following Cardiac Transplantation.
    Raza FS; Lee AY; Jamil AK; Qin H; Felius J; Rafael AE; Gonzalez-Stawinski GV; Hall SA; Joseph SM; Lima B; Bindra AS
    Am J Cardiol; 2018 Dec; 122(11):1902-1908. PubMed ID: 30442225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the International Society for Heart and Lung Transplantation (ISHLT) criteria for primary graft dysfunction after cardiac transplantation: outcomes from a high-volume centre†.
    Squiers JJ; Saracino G; Chamogeorgakis T; MacHannaford JC; Rafael AE; Gonzalez-Stawinski GV; Hall SA; DiMaio JM; Lima B
    Eur J Cardiothorac Surg; 2017 Feb; 51(2):263-270. PubMed ID: 28186268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved outcomes from extracorporeal membrane oxygenation versus ventricular assist device temporary support of primary graft dysfunction in heart transplant.
    Takeda K; Li B; Garan AR; Topkara VK; Han J; Colombo PC; Farr MA; Naka Y; Takayama H
    J Heart Lung Transplant; 2017 Jun; 36(6):650-656. PubMed ID: 28087104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Outcome in Severe Left Ventricular Primary Graft Dysfunction Post Cardiac Transplantation Supported by Early Use of Extracorporeal Membrane Oxygenation.
    Connolly S; Granger E; Hayward C; Huang D; Kerr S; McCanny P; Buscher H
    Transplantation; 2020 Oct; 104(10):2189-2195. PubMed ID: 31895346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices.
    Truby LK; Takeda K; Topkara VK; Takayama H; Garan AR; Yuzefpolskaya M; Colombo P; Naka Y; Farr M
    J Heart Lung Transplant; 2018 Dec; 37(12):1433-1442. PubMed ID: 30206023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term mechanical circulatory support for severe primary graft dysfunction following orthotopic heart transplant.
    Hulman M; Artemiou P; Ondrusek M; Hudec V; Gasparovic I; Bena M; Glonek I
    Interact Cardiovasc Thorac Surg; 2018 Aug; 27(2):229-233. PubMed ID: 29514222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoplegia after heart transplantation: outcomes at 1 year.
    Chan JL; Kobashigawa JA; Aintablian TL; Li Y; Perry PA; Patel JK; Kittleson MM; Czer LS; Zarrini P; Velleca A; Rush J; Arabia FA; Trento A; Esmailian F
    Interact Cardiovasc Thorac Surg; 2017 Aug; 25(2):212-217. PubMed ID: 28459983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, predictors, and outcomes after severe primary graft dysfunction in pediatric heart transplant recipients.
    Profita EL; Gauvreau K; Rycus P; Thiagarajan R; Singh TP
    J Heart Lung Transplant; 2019 Jun; 38(6):601-608. PubMed ID: 30733156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoplegia after implantation of a continuous flow left ventricular assist device: incidence, outcomes and predictors.
    de Waal EEC; van Zaane B; van der Schoot MM; Huisman A; Ramjankhan F; van Klei WA; Marczin N
    BMC Anesthesiol; 2018 Dec; 18(1):185. PubMed ID: 30526494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device Implantation.
    Tecson KM; Lima B; Lee AY; Raza FS; Ching G; Lee CH; Felius J; Baxter RD; Still S; Collier JDG; Hall SA; Joseph SM
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29773577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Severe Primary Graft Dysfunction in Infants Following Heart Transplant.
    Singh TP; Profita EL; Rycus P; Thiagarajan R; Gauvreau K
    J Am Heart Assoc; 2021 Jul; 10(13):e021082. PubMed ID: 34184543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracorporeal membrane oxygenation as a salvage therapy for patients with severe primary graft dysfunction after heart transplant.
    Jacob S; Lima B; Gonzalez-Stawinski GV; El-Sayed Ahmed MM; Patel PC; Belli EV; Makey IA; Thomas M; Landolfo K; Landolfo C; Leoni Moreno JC; Yip DS; Pham SM
    Clin Transplant; 2019 May; 33(5):e13538. PubMed ID: 30870577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoplegia Following Orthotopic Heart Transplantation: Prevalence, Predictors and Clinical Outcomes.
    Batchelor RJ; Wong N; Liu DH; Chua C; William J; Tee SL; Sata Y; Bergin P; Hare J; Leet A; Taylor AJ; Patel HC; Burrell A; McGiffin D; Kaye DM
    J Card Fail; 2022 Apr; 28(4):617-626. PubMed ID: 34974975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoplegia After Surgical Left Ventricular Restoration: 2-Year Follow-Up.
    van Vessem ME; Palmen M; Couperus LE; Stijnen T; Berendsen RR; Aarts LPHJ; de Jonge E; Klautz RJM; Schalij MJ; Beeres SLMA
    Ann Thorac Surg; 2018 Nov; 106(5):1371-1378. PubMed ID: 30118711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-operative risk factors and clinical outcomes associated with vasoplegia in recipients of orthotopic heart transplantation in the contemporary era.
    Patarroyo M; Simbaqueba C; Shrestha K; Starling RC; Smedira N; Tang WH; Taylor DO
    J Heart Lung Transplant; 2012 Mar; 31(3):282-7. PubMed ID: 22112993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoplegia after pediatric cardiac transplantation in patients supported with a continuous flow ventricular assist device.
    Sacks LD; Hollander SA; Zhang Y; Ryan KR; Ford MA; Maeda K; Murray JM; Almond CS; Kwiatkowski DM
    J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2433-2440. PubMed ID: 30929985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and Impact of On-Cardiopulmonary Bypass Vasoplegia During Heart Transplantation.
    Truby LK; Takeda K; Farr M; Beck J; Yuzefpolskaya M; Colombo PC; Topkara VK; Mancini D; Naka Y; Takayama H
    ASAIO J; 2018; 64(1):43-51. PubMed ID: 28777136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reoperative sternotomy is associated with primary graft dysfunction following heart transplantation.
    Still S; Shaikh AF; Qin H; Felius J; Jamil AK; Saracino G; Chamogeorgakis T; Rafael AE; MacHannaford JC; Joseph SM; Hall SA; Gonzalez-Stawinski GV; Lima B
    Interact Cardiovasc Thorac Surg; 2018 Sep; 27(3):343-349. PubMed ID: 29584854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing Predictors and Severity of Vasoplegia Syndrome After Heart Transplantation.
    Chan JL; Kobashigawa JA; Aintablian TL; Dimbil SJ; Perry PA; Patel JK; Kittleson MM; Czer LS; Zarrini P; Velleca A; Rush J; Arabia FA; Trento A; Esmailian F
    Ann Thorac Surg; 2018 Mar; 105(3):770-777. PubMed ID: 29289367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case series: the outcomes, support duration, and graft function recovery after VA-ECMO use in primary graft dysfunction after heart transplantation.
    Kawabori M; Mastroianni MA; Zhan Y; Chen FY; Rastegar H; Warner KG; Reich JA; Vest A; DeNofrio D; Couper GS
    J Artif Organs; 2020 Jun; 23(2):140-146. PubMed ID: 31713054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.